These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical Drug Development in Epilepsy Revisited: A Proposal for a New Paradigm Streamlined Using Extrapolation. Wadsworth I; Jaki T; Sills GJ; Appleton R; Cross JH; Marson AG; Martland T; McLellan A; Smith PE; Pellock JM; Hampson LV CNS Drugs; 2016 Nov; 30(11):1011-1017. PubMed ID: 27623676 [TBL] [Abstract][Full Text] [Related]
3. A global update on cenobamate based on real-world experience in over 100 000 patients. Ferrari L; Rosenfeld WE; Kamin M Epilepsia; 2024 Apr; 65(4):1149-1150. PubMed ID: 38446133 [No Abstract] [Full Text] [Related]
8. Efficacy and tolerability exposure-response relationship of retigabine (ezogabine) immediate-release tablets in patients with partial-onset seizures. Tompson DJ; Crean CS; Reeve R; Berry NS Clin Ther; 2013 Aug; 35(8):1174-1185.e4. PubMed ID: 23916044 [TBL] [Abstract][Full Text] [Related]
9. [Retigabine. A novel anticonvulsant drug for the adjunctive treatment of partial seizures]. Hecht B Med Monatsschr Pharm; 2012 May; 35(5):166-71. PubMed ID: 22624350 [No Abstract] [Full Text] [Related]
10. Ezogabine (retigabine) and its role in the treatment of partial-onset seizures: a review. Splinter MY Clin Ther; 2012 Sep; 34(9):1845-56.e1. PubMed ID: 22917854 [TBL] [Abstract][Full Text] [Related]